This study was carried out to determine the effect of recombinant human erythropoietin on prevention of anemia of prematurity. Material and Methods: From August 2008 to May 2009, 106 neonates in newborn ward at Từ Dũ Hospital were randomly assigned into erythropoietin plus iron group or iron group.